This May Be Causing Depression, And Men Don't Even Know It, Brigham and Women's Hospital Study
A new study indicates that men with prostate cancer who get hormone therapy are at a much greater risk of depression.
A new study has found that older men who get testosterone-suppressing therapy for prostate cancer may be at a very high risk of developing depression.
The study, which examined 78,000 men who had been treated for early stage prostate cancer, found that 7 percent of those who got hormone-suppressing therapy became clinically depressed over the next few years — significantly higher than the typical rate of 5 percent, according to a Brigham and Women’s Hospital statement.
A new study has found that older men who get testosterone-suppressing therapy for prostate cancer may be at a very high risk of developing depression.
The study, which examined 78,000 men who had been treated for early stage prostate cancer, found that 7 percent of those who got hormone-suppressing therapy became clinically depressed over the next few years — significantly higher than the typical rate of 5 percent, according to a Brigham and Women’s Hospital statement.